Arcadia Biosciences Inc Share Price Nasdaq
Equities
US0390141051
Agricultural Chemicals
Sales 2024 * | 6.22M 496M | Sales 2025 * | 8M 638M | Capitalization | 2.66M 212M |
---|---|---|---|---|---|
Net income 2024 * | -10M -797M | Net income 2025 * | -8M -638M | EV / Sales 2024 * | 0.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.35
x | P/E ratio 2025 * |
-0.42
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Arcadia Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 01/02/22 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 30/06/20 |
Kevin Comcowich
CHM | Chairman | 55 | 31/10/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 09/08/17 |
Gregory Waller
BRD | Director/Board Member | 74 | 12/06/17 |
Kevin Comcowich
CHM | Chairman | 55 | 31/10/16 |
1st Jan change | Capi. | |
---|---|---|
+19.30% | 39.89B | |
-.--% | 11.22B | |
-1.90% | 7.72B | |
+2.38% | 6.54B | |
-5.50% | 5.97B | |
-4.27% | 5.7B | |
-11.80% | 5.52B | |
+29.81% | 5.13B | |
-15.99% | 4.44B |